JPS6338322B2 - - Google Patents

Info

Publication number
JPS6338322B2
JPS6338322B2 JP53102362A JP10236278A JPS6338322B2 JP S6338322 B2 JPS6338322 B2 JP S6338322B2 JP 53102362 A JP53102362 A JP 53102362A JP 10236278 A JP10236278 A JP 10236278A JP S6338322 B2 JPS6338322 B2 JP S6338322B2
Authority
JP
Japan
Prior art keywords
salt
group
test
acid derivative
agent containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53102362A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5528955A (en
Inventor
Hiroshi Kodama
Masao Nakabayashi
Yoshifumi Nakajima
Takashi Nagai
Toshuki Matsukawa
Mikio Kawabata
Isao Myokan
Tetsuya Kajita
Masaaki Shibata
Kyoshi Goda
Takashi Sano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to JP10236278A priority Critical patent/JPS5528955A/ja
Publication of JPS5528955A publication Critical patent/JPS5528955A/ja
Publication of JPS6338322B2 publication Critical patent/JPS6338322B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10236278A 1978-08-24 1978-08-24 Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same. Granted JPS5528955A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10236278A JPS5528955A (en) 1978-08-24 1978-08-24 Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10236278A JPS5528955A (en) 1978-08-24 1978-08-24 Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same.

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP10475586A Division JPS6294A (ja) 1986-05-09 1986-05-09 新規なグリセロリン酸誘導体およびその塩並びにそれらの製造法

Publications (2)

Publication Number Publication Date
JPS5528955A JPS5528955A (en) 1980-02-29
JPS6338322B2 true JPS6338322B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-07-29

Family

ID=14325340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10236278A Granted JPS5528955A (en) 1978-08-24 1978-08-24 Novel glycerophosphoric acid derivative, its salt, their preparation, and carcinostatic agent containing the same.

Country Status (1)

Country Link
JP (1) JPS5528955A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03135023A (ja) * 1989-10-20 1991-06-10 Tokyo Electron Ltd 基板の双方向処理装置
JPH03135022A (ja) * 1989-10-20 1991-06-10 Tokyo Electron Ltd 基板の処理装置

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3131524A1 (de) * 1981-08-08 1983-02-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung physiologischer effektoren
US4710579A (en) * 1984-11-09 1987-12-01 Takeda Chemical Industries, Ltd. 2-(acetoacetyloxy)-3-(octadecyloxy)propyl-3-trimethylammoniopropyl phosphate or a pharmaceutically acceptable salt thereof
US5340568A (en) * 1992-07-01 1994-08-23 The Procter & Gamble Company Topical composition and method containing deoxy and halo derivatives of lysophosphatidic acids for regulating skin wrinkles
US5565439A (en) * 1992-11-24 1996-10-15 The Procter & Gamble Company Methods of using lysophosphatidic acid for treating hyperproliferative conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4912662A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1972-05-17 1974-02-04
JPS49126624A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-04-18 1974-12-04
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
JPS552636A (en) * 1978-06-22 1980-01-10 Toyama Chem Co Ltd Novel lysolecithin compound and its preparation, and carcinostatics comprising it

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03135023A (ja) * 1989-10-20 1991-06-10 Tokyo Electron Ltd 基板の双方向処理装置
JPH03135022A (ja) * 1989-10-20 1991-06-10 Tokyo Electron Ltd 基板の処理装置

Also Published As

Publication number Publication date
JPS5528955A (en) 1980-02-29

Similar Documents

Publication Publication Date Title
KR960010833B1 (ko) 궤양 예방용 약제학적 조성물
DE69426376T2 (de) Substituierte Azepino (2,1-a)isochinolin Verbindungen
US4296105A (en) Derivatives of doxorubicine, their preparation and use
JPS62500871A (ja) 薬理活性を有するジペプチド化合物及びそれを含む組成物
CN102471248A (zh) 用于递送1，3-丙二磺酸的方法、化合物和组合物
HU216636B (hu) Eljárás epesavszármazékok előállítására
ES2382806T3 (es) Compuesto ácido ciclohexanocarboxílico
WO1999001103A2 (en) Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
JPH05504775A (ja) トロンビンの阻害剤および基質
JPH0137398B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS6315278B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH09505581A (ja) イノシトール三燐酸エステルの炎症性障害治療への使用
PT90740B (pt) Processo para a preparacao de oligopeptideos com aminoacidos analogos de prolina ciclicos, e de composicoes farmaceuticas que os contem
JPS6338322B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4742081A (en) Carnitine coupled pharmaceutical agents
WO1988008715A1 (en) Method of tumor inhibition in warm-blooded animals
MX2011001800A (es) Compuestos de arsenico organico y metodos para el tratamiento de cancer.
CN114072381B (zh) 氨基硫醇类化合物作为脑神经或心脏保护剂的用途
JPH0154349B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US4551453A (en) 2-(ω-Alkylaminoalkyl)- and 2-(ω-dialkylaminoalkyl-3-(4-X-benzylidene)-phthalimidines
US4165312A (en) Phosphorylated nonapeptides, processes for the preparation thereof and pharmaceutical compositions containing them
RU2084449C1 (ru) 1-бензил-2-оксотриптамин гидрохлорид и его производные, обладающие гепатозащитной активностью
NL8201320A (nl) Ester van mercapto-acylcarnitinen, werkwijze ter bereiding van en famaceutische preparaten, die deze esters bevatten.
US5286715A (en) New adamantyl comprising tripeptides, derivatives and hydrochlorides thereof, their preparation and use
CN100513415C (zh) 胆汁酸衍生物及其医药用途